168 related articles for article (PubMed ID: 21726823)
1. Downregulation of EMX2 is associated with clinical outcomes in lung adenocarcinoma patients.
Okamoto J; Kratz JR; Hirata T; Mikami I; Raz D; Segal M; Chen Z; Zhou HM; Pham P; Li H; Yagui-Beltran A; Ray MR; Koizumi K; Shimizu K; Jablons D; He B
Clin Lung Cancer; 2011 Jul; 12(4):237-44. PubMed ID: 21726823
[TBL] [Abstract][Full Text] [Related]
2. The homeobox gene EMX2 is a prognostic and predictive marker in malignant pleural mesothelioma.
Giroux Leprieur E; Hirata T; Mo M; Chen Z; Okamoto J; Clement G; Li H; Wislez M; Jablons DM; He B
Lung Cancer; 2014 Sep; 85(3):465-71. PubMed ID: 25023662
[TBL] [Abstract][Full Text] [Related]
3. EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell Carcinomas.
Yue D; Li H; Che J; Zhang Y; Tolani B; Mo M; Zhang H; Zheng Q; Yang Y; Cheng R; Jin JQ; Luh TW; Yang C; Tseng HH; Giroux-Leprieur E; Woodard GA; Hao X; Wang C; Jablons DM; He B
PLoS One; 2015; 10(7):e0132134. PubMed ID: 26132438
[TBL] [Abstract][Full Text] [Related]
4. Down-regulation of SIX3 is associated with clinical outcome in lung adenocarcinoma.
Mo ML; Okamoto J; Chen Z; Hirata T; Mikami I; Bosco-Clément G; Li H; Zhou HM; Jablons DM; He B
PLoS One; 2013; 8(8):e71816. PubMed ID: 23977152
[TBL] [Abstract][Full Text] [Related]
5. Deregulated expression of hnRNP A/B proteins in human non-small cell lung cancer: parallel assessment of protein and mRNA levels in paired tumour/non-tumour tissues.
Boukakis G; Patrinou-Georgoula M; Lekarakou M; Valavanis C; Guialis A
BMC Cancer; 2010 Aug; 10():434. PubMed ID: 20716340
[TBL] [Abstract][Full Text] [Related]
6. The downregulation of lncRNA EMX2OS might independently predict shorter recurrence-free survival of classical papillary thyroid cancer.
Gu Y; Feng C; Liu T; Zhang B; Yang L
PLoS One; 2018; 13(12):e0209338. PubMed ID: 30576338
[TBL] [Abstract][Full Text] [Related]
7. RBX1 expression is an unfavorable prognostic factor in patients with non-small cell lung cancer.
Xing R; Chen KB; Xuan Y; Feng C; Xue M; Zeng YC
Surg Oncol; 2016 Sep; 25(3):147-51. PubMed ID: 27566015
[TBL] [Abstract][Full Text] [Related]
8. BRCA1, LMO4, and CtIP mRNA expression in erlotinib-treated non-small-cell lung cancer patients with EGFR mutations.
Karachaliou N; Costa C; Gimenez-Capitan A; Molina-Vila MA; Bertran-Alamillo J; Mayo C; Massuti B; Majem M; Carcereny E; Moran T; Sanchez JJ; Viteri S; Gasco A; Wannesson L; Souglakos J; Jimeno J; Rosell R;
J Thorac Oncol; 2013 Mar; 8(3):295-300. PubMed ID: 23407556
[TBL] [Abstract][Full Text] [Related]
9. XPC mRNA level may predict relapse in never-smokers with non-small cell lung cancers.
Yeh KT; Wu YH; Lee MC; Wang L; Li CT; Chen CY; Lee H
Ann Surg Oncol; 2012 Mar; 19(3):734-42. PubMed ID: 21861227
[TBL] [Abstract][Full Text] [Related]
10. Association between downexpression of MiR-203 and poor prognosis in non-small cell lung cancer patients.
Tang R; Zhong T; Dang Y; Zhang X; Li P; Chen G
Clin Transl Oncol; 2016 Apr; 18(4):360-8. PubMed ID: 26307752
[TBL] [Abstract][Full Text] [Related]
11. Expression of the GLI family genes is associated with tumor progression in advanced lung adenocarcinoma.
Ishikawa M; Sonobe M; Imamura N; Sowa T; Shikuma K; Date H
World J Surg Oncol; 2014 Aug; 12():253. PubMed ID: 25103784
[TBL] [Abstract][Full Text] [Related]
12. Post-recurrence survival analysis of stage I non-small-cell lung cancer.
Lee K; Kim HR; Kim DK; Kim YH; Park SI; Choi SH; Han J
Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):623-629. PubMed ID: 29058973
[TBL] [Abstract][Full Text] [Related]
13. EMX2 is epigenetically silenced and suppresses growth in human lung cancer.
Okamoto J; Hirata T; Chen Z; Zhou HM; Mikami I; Li H; Yagui-Beltran A; Johansson M; Coussens LM; Clement G; Shi Y; Zhang F; Koizumi K; Shimizu K; Jablons D; He B
Oncogene; 2010 Nov; 29(44):5969-75. PubMed ID: 20697358
[TBL] [Abstract][Full Text] [Related]
14. OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.
Karoubi G; Gugger M; Schmid R; Dutly A
Interact Cardiovasc Thorac Surg; 2009 Apr; 8(4):393-7. PubMed ID: 19126554
[TBL] [Abstract][Full Text] [Related]
15. Ornithine decarboxylase mRNA expression in curatively resected non-small-cell lung cancer.
Grimminger PP; Schneider PM; Metzger R; Vallböhmer D; Danenberg KD; Danenberg PV; Hölscher AH; Brabender J
Clin Lung Cancer; 2010 Mar; 11(2):114-9. PubMed ID: 20199977
[TBL] [Abstract][Full Text] [Related]
16. Retinoic acid-related orphan receptor C isoform 2 expression and its prognostic significance for non-small cell lung cancer.
Huang Q; Fan J; Qian X; Lv Z; Zhang X; Han J; Wu F; Chen C; Du J; Guo M; Hu G; Jin Y
J Cancer Res Clin Oncol; 2016 Jan; 142(1):263-72. PubMed ID: 26319393
[TBL] [Abstract][Full Text] [Related]
17. Clinical outcomes and prognostic factors associated with the response to erlotinib in non-small-cell lung cancer patients with unknown EGFR mutational status.
Aydiner A; Yildiz I; Seyidova A
Asian Pac J Cancer Prev; 2013; 14(5):3255-61. PubMed ID: 23803112
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor receptor 1 mRNA expression as a prognostic marker in advanced non-small cell lung cancer.
Vilmar A; Santoni-Rugiu E; Cillas JG; Huarriz M; Sørensen JB
Anticancer Res; 2014 Jun; 34(6):2991-6. PubMed ID: 24922664
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
